Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Lowered to $161 at BTIG

November 5, 2021 6:48 AM
BTIG analyst Ryan Zimmerman lowered the price target on Zimmer Biomet (NYSE: ZBH) to $161.00 (from $173.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles